Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Garofalo Health Care SpAMIL:GHC 90 EV-to-EBITDA is 9.91 as of Jul. 25, 2026, which is 2% above its 10-year median of 9.72. GuruFocus rates MIL:GHC with a GF Score™ of 90/100 and a GF Value™ of €6.08 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Garofalo Health Care SpA ranks better than 57.2% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Garofalo Health Care SpA's enterprise value is €704.7 Mil.
Garofalo Health Care SpA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €71.1 Mil. Therefore, Garofalo Health Care SpA's EV-to-EBITDA for today is 9.91.
The historical rank and industry rank for Garofalo Health Care SpA's EV-to-EBITDA or its related term are showing as below:
MIL:GHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.33 Med: 9.72 Max: 58.4
Current: 9.91
During the past 11 years, the highest EV-to-EBITDA of Garofalo Health Care SpA was 58.40. The lowest was 5.33. And the median was 9.72.
MIL:GHC's EV-to-EBITDA is ranked better than 57.2% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 10.92
vs MIL:GHC: 9.91
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Garofalo Health Care SpA (MIL:GHC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Garofalo Health Care SpA's PE Ratio (TTM) for today is calculated as:
Garofalo Health Care SpA's share price for today is €5.50.
Garofalo Health Care SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.246.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Garofalo Health Care SpA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Garofalo Health Care SpA EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Garofalo Health Care SpA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Garofalo Health Care SpA's EV-to-EBITDA falls into.
Garofalo Health Care SpA's current Enterprise Value is €704.7 Mil.
Garofalo Health Care SpA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €71.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Garofalo Health Care SpA (MIL:GHC) has a EV-to-EBITDA of 9.91 as of Jul. 25, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Garofalo Health Care SpA. This is near median its historical median of 9.72. Over the past decade, Garofalo Health Care SpA's EV-to-EBITDA has ranged from 5.33 to 58.40. According to the industry distribution chart, Garofalo Health Care SpA ranks #217 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 42.8%.
Is Garofalo Health Care SpA's EV-to-EBITDA too high?
Garofalo Health Care SpA's current EV-to-EBITDA of 9.91 is near median its 10-year median of 9.72. Over the past 10 years, this metric has ranged from a low of 5.33 to a high of 58.40. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.92. Garofalo Health Care SpA's value of 9.91 is 9.2% below this industry median. Based on the distribution chart, Garofalo Health Care SpA ranks #217 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Garofalo Health Care SpA has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Garofalo Health Care SpA's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Garofalo Health Care SpA ranks #217 out of 507 companies for EV-to-EBITDA. This puts Garofalo Health Care SpA in the upper half of its industry. The industry median EV-to-EBITDA is 10.92. Garofalo Health Care SpA's value of 9.91 is 9.2% below this benchmark. Historically, Garofalo Health Care SpA's own EV-to-EBITDA has ranged from 5.33 to 58.40 over the past decade. While the company's 10-year median is 9.72 vs. the industry median of 10.92, Garofalo Health Care SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.92, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Garofalo Health Care SpA's current EV-to-EBITDA of 9.91 is 9.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Garofalo Health Care SpA. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Garofalo Health Care SpA's current EV-to-EBITDA is 9.91, which is near median its own 10-year median of 9.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Garofalo Health Care SpA stock overvalued right now?
Based on GuruFocus' analysis, Garofalo Health Care SpA (MIL:GHC) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.08, compared to a current price of €5.50 — trading 9.5% below its estimated fair value. The current EV-to-EBITDA is 9.91, which is near median its 10-year median of 9.72 and 9.2% below the Healthcare Providers & Services industry median of 10.92. Garofalo Health Care SpA's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Garofalo Health Care SpA (MIL:GHC), the current EV-to-EBITDA is 9.91 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Garofalo Health Care SpA (MIL:GHC) Overvalued in 2026?
Based on GuruFocus' analysis, Garofalo Health Care SpA stock appears to be undervalued.
The current stock price of €5.50 is trading 9.5% below its estimated GF Value™ of €6.08.
GuruFocus considers Garofalo Health Care SpA to be Modestly Undervalued.
Key valuation signals for MIL:GHC:
EV-to-EBITDA: 9.91 (near median its 10-year median of 9.72)
GF Value™: €6.08 vs. price of €5.50 (9.5% below fair value)
Industry Position: 9.2% below the Healthcare Providers & Services median (#217 of 507)
No single metric tells the full story. See the MIL:GHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Garofalo Health Care SpA is an Italian accredited private healthcare provider offering a comprehensive range of services across various areas of healthcare through diversified specialties, supported by the use of technologies and qualified personnel. The Group mainly operates in regions of northern and central Italy, which have been selected based on their attractiveness in terms of per capita healthcare spending, above-average per capita income, and well-developed internal transport infrastructure.
90GF Score
Get the complete analysis for MIL:GHC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:GHC has been successfully added to your 
